Oncogenic nucleoporin CAN/Nup214 interacts with vitamin D receptor and modulates its function

Journal of Cellular Biochemistry

Volumn 106, Issue 6, 2009, Pages 1090-1101

  Miyauchi, Yoshiteru ^a,b   Sakaguchi, Naoko ^a   Okada, Tomoko ^a   Makishima, Makoto ^c   Ozono, Keiichi ^b   Michigami, Toshimi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CAN Nup214; Nuclear pore complex; Nucleoporin; Vitamin D receptor

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLYCINE; NUCLEOPORIN; NUCLEOPORIN 214; PHENYLALANINE; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS MEMBRANE; DNA BINDING; DNA LIBRARY; IMMUNOPRECIPITATION; NONHUMAN; NUCLEAR PORE COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; NUCLEAR PORE COMPLEX PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, CALCITRIOL; RECEPTORS, GLUCOCORTICOID; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 66149100907     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22101     Document Type: Article

References (39)

1. 3. Proc Natl Acad Sci 78:4990-4994.
2. Adachi R, Honma Y, Masuno H, Kawana K, Shimomura I, Yamada S, Makishima M. 2005. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J Lipid Res 46:46-57.
3. Bednenko J, Cingolani G, Gerace L. 2003. Nucleocytoplasmic transport: Navigating the channel. Traffic 4:127-135.
4. Boer J, Surtel JB, Grosveld G. 1998. Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 18:1236-1247.
5. Calson KW, Chander SK, MaCkay AG, Coombes RC. 1992. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44:693-702.
6. Cingolani G, Bednenko J, Gillespie MT, Gerace L. 2002. Molecular basis for the recognition of a nonclassical nuclear localization signal by importin β. Mol Cell 10:1345-1353.
7. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083-1086.
8. Fornerod M, Boer J, van Baal S, Jaeglé M, von Lindern M, Murti KG, Davis D, Bonten J, Buijs A, Grosveld G. 1995. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemiaspecific chromosome rearrangements. Oncogene 10:1739-1748.
9. Fujiki R, Kim M, Sasaki Y, Yoshimura K, Kitagawa H, Kato S. 2005. Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO J 24:3881-3894.
10. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyttebroeck A, Mentens N, Somers R, MacLeod RAF, Drexler HG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska I, Marynen P, Hagemeijer A. 2004. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36:1084-1089.
11. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
12. Hsieh IC, Shimizu Y, Minoshima S, Shimizu N, Haussler CA, Jurutka PW, Haussler MR. 1998. Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor. J Cell Biochem 70:94-109.
13. Humeniuk-Polaczek R, Marcinkowska E. 2004. Impaired nuclear localization of vitamin D receptor in leukemia cells resistant to calcitoriol-induced differentiation. J Steroid Biochem Mol Biol 88:361-366.
14. Jans DA, Xiao CY, Lam MH. 2000. Nuclear targeting signal recognition: A key control point in nuclear transport? Bioessays 22:532-544.
15. Kandilci A, Mientjes E, Grosveld G. 2004. Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. Leukemia 18:337-340.
16. Kato S, Fujiki R, Kitagawa H. 2004. Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex. J Steroid Biochem Mol Biol 89-90:173-178.
17. Kraemer D, Wazniak R, Blobel G, Radu A. 1994. The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci 91:1519-1523.
18. Luo Z, Rouvinen J, Maenpaa PH. 1994. A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization. Eur J Biochem 223:381-387.
19. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316.
20. Matsubayashi Y, Fukuda M, Nishida E. 2001. Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells. J Biol Chem 276:41755-41760.
21. Mattaj IW, Englmeier L. 1998. Nucleocytoplasmic transport: The soluble phase. Annu Rev Biochem 67:265-306.
22. Michigami T, Suga A, Yamazaki M, Shimizu C, Cai G, Okada S, Ozono K. 1999. Identification of amino acid sequence in the hinge region of human vitamin D receptor that transfers a cytosolic protein to the nucleus. J Biol Chem 19:33531-33538.
23. Miyauchi Y, Michigami T, Sakaguchi N, Sekimoto T, Yoneda Y, Pike JW, Yamagata M, Ozono K. 2005. Importin 4 is responsible for ligand-independent nuclear translocation of vitamin D receptor. J Biol Chem 49:40901-40908.
24. Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687.
25. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, Sato S, Nagase T, Seki N, Ishikawa K, Tabata S. 1994. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1:27-35.
26. Ohyama Y, Ozono K, Uchida M, Yoshimura M, Shinki T, Suda T, Yamamoto O. 1996. Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 271:30381-30385.
27. 3 analogue toward vitamin D receptor function. J Biol Chem 274:32376-32381.
28. Pailillo SM, Phillips EM, Köser J, Sauder U, Ullman KS, Powers MA, Fahrenkrog B. 2005. Nucleoporin domain topology is linked to the transport status of the nuclear pore complex. J Mol Biol 351:784-798.
29. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of -catenin signaling. J Cell Biol 154:369-387.
30. 3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood 93:2721-2729.
31. Rout MP, Aitchson JD. 2001. The nuclear pore complex as a transport machine. J Biol Chem 276:16593-16596.
32. 3. Cancer Res 54:4057-4064.
33. 3. Endocrinology 136:20-26.
34. Stewart M, Baker RP, Bayliss R, Clayton L, Grant RP, Littlewood T, Matsuura Y. 2001. Molecular mechanism of translocation through nuclear pore complexes during nuclear protein import. FEBS Lett 498:145-149.
35. 2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214. EMBO J 15:5574-5583.
36. von Lindern M, Fornerod M, van Baal S, Jaeglé M, de Wit T, Buijs A, Grosveld G. 1992. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 12:1687-1697.
37. Walther TC, Pickersgill HS, Cordes VC, Goldberg MW, Allen TD, Mattaj IW, Fornerod M. 2002. The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J Cell Biol 158:63-77.
38. Xu L, Kang Y, Col S, Massague J. 2002. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell 10:271-282.
39. Yang ES, Maiorino CA, Roos BA, Knight SR, Burnstein KL. 2002. Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer. Mol Cell Endocrinol 186:69-79.